Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching
Definium Therapeutics reported a second successful Phase 3 trial in generalized anxiety disorder for DT120, with a 9.8-point decline on the Hamilton Anxiety Rating Scale at the 100-microgram dose over 12 weeks versus a 4.7-point placebo decline (5.1-point placebo-adjusted improvement).
Sep 20, 2026 ·
Yahoo Finance


















